Advertisement

Diagnosing Plasminogen Deficiency Type 1 and Ligneous Conjunctivitis
Posted: 06/13/2025 | By: Custom Content Team

With the FDA approval of plasminogen, human-tvmh (Ryplazim, Kedrion Biopharma) there is an effective treatment for plasminogen deficiency type 1 (PLGD-1), a rare systemic disorder characterized primarily by ligneous conjunctivitis. Here, test your knowledge of the PLGD-1 diagnosis.

Question 1 of 5

Which of the following best describes the first outward evidence seen in patients with plasminogen deficiency type 1 (PLGD-1)?

Choose 1

CategoriesView All Quizzes

Retina


Refractive Conditions


Cataract


Cornea


Ocular Surface Disease


Glaucoma


Systemic Disease



Conference Coverage